Last updated: May 11, 2025
Sponsor: Imugene Limited
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05822427
PBCAR-LTF
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Receipt of at least 1 dose of azer-cel in an Imugene clinical study.
A signed informed consent form (ICF).
Willingness and ability to adhere to the study schedule and all other protocolrequirements.
Exclusion
Exclusion Criteria:
- No unique exclusion criteria apply to this study.
Study Design
Total Participants: 75
Study Start date:
August 25, 2020
Estimated Completion Date:
December 31, 2039
Study Description
Connect with a study center
Science 37, Inc.
Culver City, California 90230
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.